SCHEMBL8368754

SCHEMBL8368754

COC(=O)C1Sc2ccccc2C1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.37
▸ GAA P10253 4/20 0.37
▸ POLB P06746 2/20 0.35
▸ BCHE P06276 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 4/20 0.34
▸ HTT P42858 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ GLA P06280 2/20 0.33
▸ CASP1 P29466 2/20 0.33
▸ CASP7 P55210 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ITGA4 P13612 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29155510 0.82 ALDH1A1 (0.38) ALDH1A1GAAPOLBBCHEMEN1
SCHEMBL29155511 0.79 POLB (0.41) ALDH1A1GAAPOLBHSD17B10HTT
SCHEMBL13117633 0.72 MC4R (0.38) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL18719864 0.71 KDM4E (0.42) ALDH1A1BCHEMEN1KMT2AKDM4E
SCHEMBL10850418 0.68 POLB (0.41) ALDH1A1GAAPOLBBCHEMEN1
SCHEMBL13390322 0.67 RAB9A (0.45) ALDH1A1GAAPOLBHTTMAPT
SCHEMBL24193350 0.66 CYSLTR2 (0.37) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL10895693 0.66 KMT2A (0.44) ALDH1A1GAAPOLBMEN1KMT2A
SCHEMBL12945091 0.66 GAA (0.38) ALDH1A1GAAPOLBBCHEMEN1
SCHEMBL28000462 0.65 EGFR (0.41) ALDH1A1GAAPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367653-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2013-02-05 — — US disclosed
US-20100324013-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324013-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA ALDH1A1 364/4885GAA 22/4885POLB 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback